Diagnostic Value of the Aminopeptidase N, N-Acetyl-β-D-Glucosaminidase and Dipeptidylpeptidase IV in Evaluating Tubular Dysfunction in Patients with Glomerulopathies

REFERENCES

• Cameron JS. Tubular and interstitial factors in the progression of glomerulonephritis. Pediatr. Nephrol. 1992; 6: 291–303
   Google Scholar
• Stefanovic V, Antic S. Plasma cell membrane glycoprotein 1 (PC-1): A marker of insulin resistance in obesity, uremia, and diabetes mellitus. Clin. Lab. 2004; 50: 271–278
   PubMedGoogle Scholar
• Dong H, Maddux BA, Altomonte J, Meseck M, Accili D, Terkeltaub R, Johnson K, Youngren JF, Goldfine ID, Meseck M, Accili D, Terkeltaub R, Johnson K, Youngren JF, Goldfine ID. Increased hepatic levels of the insulin receptor inhibitor, PC-1/ENPP1, induce insulin resistance and glucose intolerance. Diabetes. 2005; 54: 367–372
   PubMedGoogle Scholar
• Maddux BA, Sbraccia P, Kumakura S, Sasson S, Youngren J, Fisher A, Spencer S, Grupe A, Henzel W, Stewart TA. Membrane glycoprotein PC-1 and insulin resistance in non-insulin dependent diabetes mellitus. Nature. 1995; 373: 448–451
   PubMed Web of Science ®Google Scholar
• Kumakura S, Maddux BA, Sung CK. Overexpression of membrane glycoprotein PC-1 can influence insulin action at a postreceptor cite. J. Cell. Biochem. 1998; 68: 366–377
   PubMedGoogle Scholar
• Haugen HF, Skrede S. Nucleotide pyrophosphatase and phosphodiesterase I. Organ distribution and activities in body fluids. Clin. Chem. 1977; 23: 1531–1537
   PubMedGoogle Scholar
• Le Hir M, Dubach UC, Angielski S. Localization of nucleotide pyrophosphatase in the rat kidney. Histochemistry. 1986; 86: 207–210
   PubMedGoogle Scholar
• Stefanovic V, Vlahovic P, Ardaillou R. Characterization and control of expression of cell surface alkaline phosphodiesterase I activity in rat mesangial glomerular cells. Renal Physiol. Biochem. 1995; 18: 18–20
   Google Scholar
• Stefanovic V, Rajic M, Antic S, Mitić-Zlatković M, Stojiljković S, Ivić MA, Vlahovic P. Urinary PC-1 activity in patients with type 1 diabetes mellitus. Ann. Clin. Biochem. 2003; 40: 235–238
   PubMedGoogle Scholar
• Stefanovic V, Vlahovic P, Ardaillou N, Ronco P, Ardaillou R. Cell surface aminopeptidase A and N activities in human glomerular epithelial cells. Kidney Int. 1992; 41: 1571–1580
   PubMed Web of Science ®Google Scholar
• Dixon J, Kaklamanis L, Turley H, Hickson ID, Leek RD, Harris AL, Gatter KC. Expression of aminopeptidase-n (CD 13) in normal tissues and malignant neoplasms of epithelial and lymphoid origin. J. Clin. Pathol. 1994; 47: 43–47
   PubMed Web of Science ®Google Scholar
• Stefanovic V, Vlahovic P, Ardaillou N, Ronco P, Nivez MP, Ardaillou R. Characterisation and control of expression of cell surface aminopeptidase N activity in human mesangial glomerular cells. Cell. Physiol. Biochem. 1992; 2: 57–68
   Google Scholar
• Holdt-Lehmann B, Lehmann A, Korten G, Nagel H, Nizze H, Schuff-Werner P. Diagnostic value of urinary alanine aminopeptidase and N-acetyl-beta-D-glucosaminidase in comparison to alpha 1-microglobulin as a marker in evaluating tubular dysfunction in glomerulonephritis patients. Clin Chim Acta. 2000; 297: 93–102
   PubMed Web of Science ®Google Scholar
• Jones AP, Lock S, Griffiths KD. Urinary N-acetyl-β-D-glucosaminidase activity in type 1 diabetes mellitus. Ann Clin Biochem. 1995; 32: 58–62
   PubMedGoogle Scholar
• Mocan Z, Erem C, Yildirim M, Telatar M, Deger C. Urinary β2-microglobulin levels and urinary N-acetyl-β-D-glucosaminidase enzyme activities in early diagnosis of non-insulin dependent diabetes mellitus nephropathy. Diabetes Res. 1994; 26: 101–107
   PubMedGoogle Scholar
• Chatelet F, Brianti E, Ronco P, Roland J, Verroust P. Ultrastructural localization by monoclonal antibodies of brush border antigens expressed by glomeruli. I. Renal distribution. Am J Pathol. 1986; 122: 500–511
   PubMedGoogle Scholar
• Green BD, Flatt PR, Bailey CJ. Inhibition of dipeptidylpeptidase IV activity as a therapy of type 2 diabetes. Expert Opin Emerg Drugs. 2006; 11: 525–539
   PubMedGoogle Scholar
• Haugen HF, Skrede S. Nucleotide pyrophosphatase and phosphodiesterase I. Organ distribution and activities in body fluids. Clin Chem. 1977; 23: 1531–1537
   PubMedGoogle Scholar
• Horak E, Hopfer SM, Sunderman W. Spectrophotometric assay for urinary N-acetyl-β-D-glucosaminidase activity. Clin Chem. 1981; 27: 1180–1185
   PubMed Web of Science ®Google Scholar
• Stefanovic V, Ardaillou N, Vlahovic P, Placier S, Ronco P, Ardaillou R. Interferon-γ induces dipeptidylpeptidase IV expression in human glomerular epithelial cells. Immunology. 1993; 80: 465–470
   PubMed Web of Science ®Google Scholar
• Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med. 1998; 339: 1448–1456
   PubMed Web of Science ®Google Scholar
• Idris I, Donnelly R. Dipeptidyl peptidase-IV inhibitors: A major new class of oral antidiabetic drug. Diabetes Obes Metab. 2007; 9: 153–165
   PubMed Web of Science ®Google Scholar
• Stefanovic V, Antic S, Mitic-Zlatkovic M, Vlahovic P. Reversal of increased lymphocyte PC-1 activity in patients with type 2 diabetes treated with metformin. Diabetes Metab Res Rev. 1999; 15: 400–404
   PubMed Web of Science ®Google Scholar
• Bazzi C, Petrini C, Rizza V, Arrigo G, Napodano P, Paparella M, D'Amico G. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Nephrol Dial Transpant. 2002; 17: 1890–1896
   PubMed Web of Science ®Google Scholar
• Rajic M, Ilic S, Vlajkovic M, Antic S, Velickovic L, Stefanovic V. Radionuclide staging of renal function in type 1 diabetes mellitus. Ren Fail. 2007; 29: 685–691
   PubMed Web of Science ®Google Scholar
• Weitgasser R, Schnoell F, Gappmayer B, Kartnig I. Prospective evaluation of urinary N-acetyl-beta-D-glucosaminidase with respect to macrovascular disease in elderly type 2 diabetic patients. Diabetes Care. 1999; 22: 1882–1886
   PubMedGoogle Scholar
• Navarro JF, Mora C, Muros M, Maca M, Garca J. Effects of pentoxifylline administration on urinary N-acetyl-beta-glucosaminidase excretion in type 2 diabetic patients: A short-term, prospective, randomized study. Am J Kidney Dis. 2003; 42: 264–270
   PubMedGoogle Scholar
• Hsiao PH, Tsai WS, Tsai WY, Lee JS, Tsau YK, Chen CH. Urinary N-acetyl-beta-D-glucosaminidase activity in children with insulin-dependent diabetes mellitus. Am J Nephrol. 1996; 16: 300–303
   PubMedGoogle Scholar